NMRA-140
Showing 1 - 25 of 606
MDD Trial in United States (BTRX-335140, Placebo)
Active, not recruiting
- Major Depressive Disorder
- BTRX-335140
- Placebo
-
Phoenix, Arizona
- +37 more
Mar 11, 2022
MDD Trial (NMRA-335140, Placebo)
Not yet recruiting
- Major Depressive Disorder
- NMRA-335140
- Placebo
- (no location specified)
Sep 21, 2023
MDD Trial (NMRA-335140, Placebo)
Not yet recruiting
- Major Depressive Disorder
- NMRA-335140
- Placebo
- (no location specified)
Sep 21, 2023
MDD Trial (NMRA 335140, Placebo)
Not yet recruiting
- Major Depressive Disorder
- NMRA 335140
- Placebo
- (no location specified)
Sep 1, 2023
Osteoarthritis Wrist Trial (Self-managed exercise therapy program, Partial wrist denervation)
Not yet recruiting
- Osteoarthritis Wrist
- Self-managed exercise therapy program
- Partial wrist denervation
- (no location specified)
Oct 24, 2023
Medullary Thyroid Cancer Trial in Worldwide (Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet)
Active, not recruiting
- Medullary Thyroid Cancer
- Cabozantinib (XL184) 140 mg
- +3 more
-
St. Leonards, New South Wales, Australia
- +49 more
Jan 23, 2023
CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at
Withdrawn
- CCR5
- +3 more
- 700mg leronlimab weekly dose
- +3 more
- (no location specified)
Feb 15, 2023
Blood Pressure, Perioperative Hypotension Trial in Hamburg (Continuous norepinephrine infusion via an infusion pump, Manual
Not yet recruiting
- Blood Pressure
- Perioperative Hypotension
- Continuous norepinephrine infusion via an infusion pump
- Manual bolus norepinephrine administration
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Aug 10, 2023
Systemic Lupus Erythematosus Trial (GLPG3667, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- GLPG3667
- Placebo
- (no location specified)
May 4, 2023
Preeclampsia Trial (Antihypertensive treatment)
Not yet recruiting
- Preeclampsia
- Antihypertensive treatment
- (no location specified)
Jan 9, 2023
Time Spent In Target Glucose Range in T2D Diabetes in Pregnancy
Recruiting
- Diabete Type 2
- Pregnancy in Diabetic
- Dexcom Continuous Glucose Monitoring
-
Toronto, Ontario, CanadaMount Sinai Hospital
Nov 21, 2023
The CARDIO-TTRansform Scintigraphy Sub-study
Active, not recruiting
- Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
- Scintigraphy scan
-
New York, New York
- +4 more
Oct 4, 2023
Essential Hypertension, Primary Hypertension Trial (Amicomed®, Digital Placebo, Usual Care)
Not yet recruiting
- Essential Hypertension
- Primary Hypertension
- Amicomed®
- +2 more
- (no location specified)
Oct 19, 2023
Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))
Completed
- Coronavirus Disease 2019
- Placebo
- Leronlimab (700mg)
-
Los Angeles, California
- +11 more
Dec 8, 2022
Hyperlipidemia, Mixed Dyslipidemia Trial in Denver (Evolocumab)
Completed
- Hyperlipidemia
- Mixed Dyslipidemia
- Evolocumab
-
Denver, ColoradoResearch Site
Nov 3, 2022
HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)
Active, not recruiting
- HIV-1-infection
- PRO 140 350
- +2 more
-
San Francisco, CaliforniaQuest Clinical Research
Mar 4, 2022
Hypertension Trial in United States (Anti-hypertensive therapy, No anti-hypertensive therapy (unless BP is severe))
Completed
- Hypertension
- Anti-hypertensive therapy
- No anti-hypertensive therapy (unless BP is severe)
-
Birmingham, Alabama
- +71 more
Dec 16, 2022
End Stage Renal Disease on Dialysis Trial in San Francisco, Seattle (Dry weight target adjustment, Anti-hypertensive
Recruiting
- End Stage Renal Disease on Dialysis
- Dry weight target adjustment
- Anti-hypertensive medications
-
San Francisco, California
- +1 more
Jun 2, 2022
Menopausal Hot Flashes Trial in Oakland, San Francisco (transdermal nitroglycerin, Placebo)
Completed
- Menopausal Hot Flashes
- transdermal nitroglycerin
- Placebo
-
Oakland, California
- +1 more
Dec 14, 2022
Diabetes, Type 2 Trial in United States (Blinded CGM, real-time CGM)
Recruiting
- Diabetes Mellitus, Type 2
- Blinded CGM
- real-time CGM
-
Aurora, Colorado
- +5 more
Nov 23, 2022
Solid Tumor, Adult Trial in San Francisco (Leronlimab)
Active, not recruiting
- Solid Tumor, Adult
-
San Francisco, CaliforniaQuest Clinical Research
Jun 30, 2022
Lower Eyelid Steatoblepharon Trial in Newport Beach (POLAT-001, Placebo)
Recruiting
- Lower Eyelid Steatoblepharon
- POLAT-001
- Placebo
-
Newport Beach, CaliforniaMedical Associates, Inc.
Jun 29, 2023
Ultrasound for Socket Healing Evaluation
Not yet recruiting
- Healing Wound
- +4 more
- (no location specified)
Aug 23, 2023
HIV Trial in United States (PRO 140 (350 mg), PRO 140 (525 mg), PRO 140 (700 mg))
Active, not recruiting
- HIV
- PRO 140 (350 mg)
- +2 more
-
La Mesa, California
- +11 more
Jan 13, 2022